These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35104298)

  • 21. Are Target Urate and Remission Possible in Severe Gout? A Five-year Cohort Study.
    Alvarado-de la Barrera C; López-López CO; Álvarez-Hernández E; Peláez-Ballestas I; Gómez-Ruiz C; Burgos-Vargas R; Vázquez-Mellado J
    J Rheumatol; 2020 Jan; 47(1):132-139. PubMed ID: 31043541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank.
    Narang RK; Topless R; Cadzow M; Gamble G; Stamp LK; Merriman TR; Dalbeth N
    Arthritis Res Ther; 2019 Jan; 21(1):13. PubMed ID: 30626429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of change in urate deposition by dual-energy computed tomography among clinically stable patients with long-standing tophaceous gout: a prospective longitudinal study.
    Rajan A; Aati O; Kalluru R; Gamble GD; Horne A; Doyle AJ; McQueen FM; Dalbeth N
    Arthritis Res Ther; 2013 Oct; 15(5):R160. PubMed ID: 24286500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the causal effects of blood lipid levels on gout with summary level GWAS data: two-sample Mendelian randomization and mediation analysis.
    Yu X; Wang T; Huang S; Zeng P
    J Hum Genet; 2021 May; 66(5):465-473. PubMed ID: 33100326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regular pre-admission urate-lowering therapy and serum urate testing are associated with a shorter hospital length of stay in people with gout: A nation-wide population-based cohort study.
    Jatuworapruk K; Grainger R; Dalbeth N; Taylor WJ
    Int J Rheum Dis; 2022 Feb; 25(2):154-162. PubMed ID: 34796661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal handling of uric acid in gout: impaired tubular transport of urate not dependent on serum urate levels.
    García Puig J; Mateos Antón F; López Jiménez M; Conthe Gutiérrez P
    Metabolism; 1986 Dec; 35(12):1147-53. PubMed ID: 3784914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase.
    Mandell BF; Yeo AE; Lipsky PE
    Arthritis Res Ther; 2018 Dec; 20(1):286. PubMed ID: 30594229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis.
    Lukkunaprasit T; Rattanasiri S; Turongkaravee S; Suvannang N; Ingsathit A; Attia J; Thakkinstian A
    BMC Med Genet; 2020 Oct; 21(1):210. PubMed ID: 33087043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum urate as a soluble biomarker in chronic gout-evidence that serum urate fulfills the OMERACT validation criteria for soluble biomarkers.
    Stamp LK; Zhu X; Dalbeth N; Jordan S; Edwards NL; Taylor W
    Semin Arthritis Rheum; 2011 Jun; 40(6):483-500. PubMed ID: 21056459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum urate levels and therapy in adults treated with long-term dialysis: a retrospective cross-sectional study.
    Yeo E; Palmer SC; Chapman PT; Frampton C; Stamp LK
    Intern Med J; 2019 Jul; 49(7):838-842. PubMed ID: 30426652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The performance of dual-energy CT in the classification criteria of gout: a prospective study in subjects with unclassified arthritis.
    Gamala M; Jacobs JWG; Linn-Rasker SF; Nix M; Heggelman BGF; Pasker-de Jong PCM; van Laar JM; Klaasen R
    Rheumatology (Oxford); 2020 Apr; 59(4):845-851. PubMed ID: 31504985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between ferritin and urate levels and risk of gout.
    Fatima T; McKinney C; Major TJ; Stamp LK; Dalbeth N; Iverson C; Merriman TR; Miner JN
    Arthritis Res Ther; 2018 Aug; 20(1):179. PubMed ID: 30111358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation.
    Li S; Cheng J; Cui L; Gurol ME; Bhatt DL; Fonarow GC; Benjamin EJ; Xing A; Xia Y; Wu S; Gao X
    J Am Heart Assoc; 2019 Jul; 8(13):e012020. PubMed ID: 31213103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.
    Doherty M; Jenkins W; Richardson H; Sarmanova A; Abhishek A; Ashton D; Barclay C; Doherty S; Duley L; Hatton R; Rees F; Stevenson M; Zhang W
    Lancet; 2018 Oct; 392(10156):1403-1412. PubMed ID: 30343856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of serum and synovial fluid levels of uric acid between patients with gout and other arthritides.
    Wangkaew S; Kasitanon N; Hongsongkiat S; Tanasombat C; Sukittawut W; Louthrenoo W
    J Med Assoc Thai; 2014 Jul; 97(7):679-85. PubMed ID: 25265764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study.
    Stamp LK; Frampton C; Drake J; Doughty RN; Troughton RW; Richards AM
    Arthritis Rheumatol; 2019 Oct; 71(10):1733-1738. PubMed ID: 31162825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.
    Latourte A; Bardin T; Clerson P; Ea HK; Flipo RM; Richette P
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):918-924. PubMed ID: 28834411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.
    Robinson PC; Taylor WJ; Dalbeth N
    J Rheumatol; 2015 Sep; 42(9):1702-7. PubMed ID: 26233513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.